- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-26-0460386

Nanobot Pharmaceuticals Private Limited
About Nanobot Pharmaceuticals Private Limited
Data last updated:
Nanobot Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2020PTC189987.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudhakar Jarasandh Chavan and Priyanka Sudhakar Chavan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fl No.M – 205 Sr No.491/1/2/3/4/5A/5B/6/7 Tanish Orchid Charholi Bk, Pune, Maharashtra, India – 412105.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.4 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹49,084 (net margin 2.4%) and EBITDA of ₹58,156 (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Nanobot Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0460386).
Company details
Recognitions & Rankings of Nanobot Pharmaceuticals
Contact details
Nanobot Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressFl No.M – 205 Sr No.491/1/2/3/4/5A/5B/6/7 Tanish Orchid Charholi Bk, Pune, Maharashtra, India – 412105
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nanobot Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nanobot Pharmaceuticals Private Limited, buy the company report.
Financials of Nanobot Pharmaceuticals Private Limited
FY 2025 filings availableNanobot Pharmaceuticals Private Limited reported revenue of ₹20.4 Lakh (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years, including 24% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58,156 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49,084 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nanobot Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nanobot Pharmaceuticals Private Limited
Nanobot Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhakar Jarasandh Chavan | Director | 19 Feb 2020 | 6 Years 8 Months | Current |
| Priyanka Sudhakar Chavan | Director | 19 Feb 2020 | 6 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Nanobot Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nanobot Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nanobot Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nanobot Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Priyanka Sudhakar Chavan was appointed as Director on 19 Feb 2020.
Frequently asked questions
Nanobot Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 February 2020 (6+ years old) and is registered under CIN U24230PN2020PTC189987.
Nanobot Pharmaceuticals has 2 current directors:
- Sudhakar Jarasandh Chavan - Director
- Priyanka Sudhakar Chavan - Director
The latest financial statements of Nanobot Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Nanobot Pharmaceuticals is U24230PN2020PTC189987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nanobot Pharmaceuticals was incorporated on 19 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Priyanka Sudhakar Chavan was appointed as Director on 19 Feb 2020. Sudhakar Jarasandh Chavan was appointed as Director on 19 Feb 2020.
Yes, Nanobot Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0460386).
The registered office of Nanobot Pharmaceuticals is at Fl No.M – 205 Sr No.49112345A5B67 Tanish Orchid Charholi Bk, Pune, Maharashtra, India – 412105.
Nanobot Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Nanobot Pharmaceuticals can be reached at its registered office: Fl No.M – 205 Sr No.49112345A5B67 Tanish Orchid Charholi Bk, Pune, Maharashtra, India – 412105.

